Should a hysterosalpingogram be a first-line investigation to diagnose female tubal subfertitlity in the modern subfertility workup?

Chou Pay Lim, Zaid Hasafa, Siladitya Bhattacharya, Abha Maheshwari

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Tubal assessment is an integral part of female fertility evaluation. While diagnostic laparoscopy is gold standard, it is not
suitable to be used as a screening test. Hysterosalpingogram (HSG) has been advocated as first-line investigation historically. With advances
in diagnostics, more tests are available, such as hysterosalpingo contrast sonography (HyCoSy) and Chlamydia antibody titre (CAT) are available.
The CAT test is much cheaper, less invasive and can be performed at any time during the cycle. The CAT test can also be used as a
means of identifying which patients need further evaluation. HyCoSy has same diagnostic accuracy as HSG, without exposing women to
radiation. We argue that HSG is out of date and has no place in a modern infertility evaluation. We also suggest a pathway (based on
history, clinical and ultrasound evaluation) for investigations to screen for and diagnose tubal pathology.
Original languageEnglish
Pages (from-to)967-971
Number of pages5
JournalHuman Reproduction
Volume26
Issue number5
Early online date26 Feb 2011
DOIs
Publication statusPublished - May 2011

Fingerprint

Infertility
Chlamydia
Antibodies
Ultrasonography
Routine Diagnostic Tests
Laparoscopy
Fertility
Pathology

Keywords

  • tubal patency test
  • hysterosalpingogram
  • hysterosalpingo contrast sonography
  • chlamydia antibody titre
  • infertility

Cite this

@article{c885e2ab4cd44fe2be20fcb8c5e71503,
title = "Should a hysterosalpingogram be a first-line investigation to diagnose female tubal subfertitlity in the modern subfertility workup?",
abstract = "Tubal assessment is an integral part of female fertility evaluation. While diagnostic laparoscopy is gold standard, it is not suitable to be used as a screening test. Hysterosalpingogram (HSG) has been advocated as first-line investigation historically. With advances in diagnostics, more tests are available, such as hysterosalpingo contrast sonography (HyCoSy) and Chlamydia antibody titre (CAT) are available. The CAT test is much cheaper, less invasive and can be performed at any time during the cycle. The CAT test can also be used as a means of identifying which patients need further evaluation. HyCoSy has same diagnostic accuracy as HSG, without exposing women to radiation. We argue that HSG is out of date and has no place in a modern infertility evaluation. We also suggest a pathway (based on history, clinical and ultrasound evaluation) for investigations to screen for and diagnose tubal pathology.",
keywords = "tubal patency test , hysterosalpingogram, hysterosalpingo contrast sonography , chlamydia antibody titre , infertility",
author = "Lim, {Chou Pay} and Zaid Hasafa and Siladitya Bhattacharya and Abha Maheshwari",
year = "2011",
month = "5",
doi = "10.1093/humrep/der046",
language = "English",
volume = "26",
pages = "967--971",
journal = "Human Reproduction",
issn = "0268-1161",
publisher = "OXFORD UNIV PRESS",
number = "5",

}

TY - JOUR

T1 - Should a hysterosalpingogram be a first-line investigation to diagnose female tubal subfertitlity in the modern subfertility workup?

AU - Lim, Chou Pay

AU - Hasafa, Zaid

AU - Bhattacharya, Siladitya

AU - Maheshwari, Abha

PY - 2011/5

Y1 - 2011/5

N2 - Tubal assessment is an integral part of female fertility evaluation. While diagnostic laparoscopy is gold standard, it is not suitable to be used as a screening test. Hysterosalpingogram (HSG) has been advocated as first-line investigation historically. With advances in diagnostics, more tests are available, such as hysterosalpingo contrast sonography (HyCoSy) and Chlamydia antibody titre (CAT) are available. The CAT test is much cheaper, less invasive and can be performed at any time during the cycle. The CAT test can also be used as a means of identifying which patients need further evaluation. HyCoSy has same diagnostic accuracy as HSG, without exposing women to radiation. We argue that HSG is out of date and has no place in a modern infertility evaluation. We also suggest a pathway (based on history, clinical and ultrasound evaluation) for investigations to screen for and diagnose tubal pathology.

AB - Tubal assessment is an integral part of female fertility evaluation. While diagnostic laparoscopy is gold standard, it is not suitable to be used as a screening test. Hysterosalpingogram (HSG) has been advocated as first-line investigation historically. With advances in diagnostics, more tests are available, such as hysterosalpingo contrast sonography (HyCoSy) and Chlamydia antibody titre (CAT) are available. The CAT test is much cheaper, less invasive and can be performed at any time during the cycle. The CAT test can also be used as a means of identifying which patients need further evaluation. HyCoSy has same diagnostic accuracy as HSG, without exposing women to radiation. We argue that HSG is out of date and has no place in a modern infertility evaluation. We also suggest a pathway (based on history, clinical and ultrasound evaluation) for investigations to screen for and diagnose tubal pathology.

KW - tubal patency test

KW - hysterosalpingogram

KW - hysterosalpingo contrast sonography

KW - chlamydia antibody titre

KW - infertility

U2 - 10.1093/humrep/der046

DO - 10.1093/humrep/der046

M3 - Article

VL - 26

SP - 967

EP - 971

JO - Human Reproduction

JF - Human Reproduction

SN - 0268-1161

IS - 5

ER -